ARID1A loss leads to chemotherapy resistance and is associated with a poor clinic outcome for patients with non-small cell lung cancer

被引：1
|
作者：
Yang, Linlin [1 ]
Shen, Changxian [1 ]
Mo, Xiaokui [2 ]
Williams, Terence M. [1 ]
机构：
[1] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-4155
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4155
引用
收藏
页数：2
相关论文
共 50 条
  • [31] CHEMOTHERAPY RESISTANCE AND ONCOGENE EXPRESSION IN NON-SMALL CELL LUNG CANCER
    Li, Yin
    Zheng, Shiying
    Jiang, Dong
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S721 - S722
  • [32] DOWNREGULATION OF CD44 LEADS TO THERAPEUTIC RESISTANCE AND POOR PROGNOSIS IN NON-SMALL CELL LUNG CANCER
    Choi, C. M.
    Park, Y. S.
    Lee, J. C.
    Park, M. J.
    Kim, H. R.
    ANNALS OF ONCOLOGY, 2013, 24 : 27 - 27
  • [33] Factors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancer
    Salloum, Ramzi G.
    Smith, Thomas J.
    Jensen, Gail A.
    Lafata, Jennifer Elston
    LUNG CANCER, 2012, 75 (02) : 255 - 260
  • [34] NANOG Predicts Poor Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
    Lee, Seung Hyeun
    Park, Myung Jae
    Park, So Young
    In, Kwang Ho
    Kim, Chul Hwan
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S959 - S960
  • [35] Chemotherapy in non-small cell lung cancer
    Sweeney, CJ
    Sandler, AB
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (02) : 157 - 186
  • [36] Chemotherapy in Non-Small Cell Lung Cancer
    Christopher J. Sweeney
    Alan B. Sandler
    Investigational New Drugs, 2000, 18 : 157 - 186
  • [37] LKB1 loss is associated with resistance to VEGF inhibitors in non-small cell lung cancer (NSCLC)
    Guijarro, Irene
    Poteete, Alissa
    Yang, Chao
    Roarty, Emily
    Nilsson, Monique
    Sun, Huiying
    Tong, Pan
    Chang, Edward
    Rodriguez-Canales, Jaime
    Mino, Barbara
    Parra, Edwin
    Wistuba, Ignacio
    Wang, Jing
    Heffernan, Timothy
    Heymach, John V.
    CANCER RESEARCH, 2016, 76
  • [38] Proteinuria: Associated with poor outcome in patients with small cell lung cancer
    Hsu, Shun-Neng
    Hsu, Yu-Juei
    Lin, Chin
    Su, Sui-Lung
    Lin, Shih-Hua
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S688 - S693
  • [39] Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome
    Tripathi, Satyendra C.
    Peters, Haley L.
    Taguchi, Ayumu
    Katayama, Hiroyuki
    Wang, Hong
    Momin, Amin
    Jolly, Mohit Kumar
    Celiktas, Muge
    Rodriguez-Canales, Jaime
    Liu, Hui
    Behrens, Carmen
    Wistuba, Ignacio I.
    Ben-Jacob, Eshel
    Levine, Herbert
    Molldrem, Jeffrey J.
    Hanash, Samir M.
    Ostrin, Edwin J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (11) : E1555 - E1564
  • [40] Reduced expression of claudin-7 is associated with poor outcome in non-small cell lung cancer
    Yamamoto, Taketsugu
    Oshima, Takashi
    Yoshihara, Kazue
    Yamanaka, Sumitaka
    Nishii, Teppei
    Arai, Hiromasa
    Inui, Kenji
    Kaneko, Takeshi
    Nozawa, Akinori
    Woo, Tetsukan
    Rino, Yasushi
    Masuda, Munetaka
    Imada, Toshio
    ONCOLOGY LETTERS, 2010, 1 (03) : 501 - 505
12345